In today’s fast-paced business world, contracts form the backbone of any successful operation. From vendor agreements to ...

VET3-T12 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Uterine Cancer.

VET3-T12 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Sarcomas. According to GlobalData, Phase I drugs for Sarcomas have a 77% phase transition success rate ...

Defining yourself isn’t about creating a fixed, unchanging identity. It’s about recognizing that you can be dynamic, flexible ...

reiterate their earlier recommendation for establishment of a single-window system and develop standardized PPA templates to set definite timelines for the approval process at each level within ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

FDA published a draft guidance titled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management ...

DYNE-101 eased myotonia and led to other functional improvements for people with myotonic dystrophy type 1 (DM1) in a ...

Policy management is the sturdy scaffolding that supports governance, risk, and compliance (GRC) objectives while shaping ...

The healthcare industry is brimming with opportunities for innovation, offering fertile ground for entrepreneurs eager to ...

Payment of lump sum under the Contributory Pension Scheme, CPS, at retirement is very important to a potential pensioner ...

PowerPatent provides a solution for startup founders to protect their software inventions. PowerPatent's AI Solutions for Cost-Effective Patent Filing offer an array of features that are meticulously ...